These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 8388217)
1. Synthesis of 7-(2-dimethylaminovinyl) derivatives of pyrazolo[1,5-a] pyrimidines, as precursors of new tricyclic series. Binding studies of BDZ receptor. Bruni F; Costanzo A; Selleri S; Guerrini G; Giusti L; Martini C; Lucacchini A Farmaco; 1993 Feb; 48(2):309-19. PubMed ID: 8388217 [TBL] [Abstract][Full Text] [Related]
2. New 2,3-substituted 4,7-dihydro-6-(1'H-pyrazol-3'-yl)pyrazolo[1,5-a] pyrimidin-7-ones and related compounds: synthesis and benzodiazepine receptor binding study. Selleri S; Bruni F; Costanzo A; Guerrini G; Casilli ML; Giusti L; Lucacchini A; Martini C Farmaco; 1995 Oct; 50(10):679-87. PubMed ID: 8590575 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. Colotta V; Catarzi D; Varano F; Filacchioni G; Cecchi L; Galli A; Costagli C J Med Chem; 1996 Jul; 39(15):2915-21. PubMed ID: 8709126 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists. Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033 [TBL] [Abstract][Full Text] [Related]
5. Tricyclic heteroaromatic systems pyrazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity. Colotta V; Cecchi L; Catarzi D; Conti G; Filacchioni G; Martini C; Giusti L; Lucacchini A Farmaco; 1993 Aug; 48(8):1051-63. PubMed ID: 8216668 [TBL] [Abstract][Full Text] [Related]
6. Pyrazolo[4,3-c]quinolines, synthesis and specific inhibition of benzodiazepine receptor binding. Note II. Savini L; Massarelli P; Corti P; Pellerano C; Bruni G; Romeo MR Farmaco; 1993 Dec; 48(12):1675-86. PubMed ID: 8135991 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists. Poulsen SA; Quinn RJ J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of 1H-pyrazolo[4,3-d]pyrimidine-7(6H)-ones and pyrazolo-5-carboxamides and interaction with benzodiazepine and adenosine A1 receptors in rat cerebral cortex. Baraldi PG; Casolari A; Manfredini S; Periotto V; Zanirato V; Florio C; Traversa V; Bertelli GM; Borea PA Arzneimittelforschung; 1988 Sep; 38(9):1262-5. PubMed ID: 2852012 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and binding study on pyrazolo[4,5-c] [1,8]naphthyridines. Cecchi L; Colotta V; Filacchioni G; Melani F; Palazzino G; Galli A Farmaco Sci; 1987 Sep; 42(9):671-80. PubMed ID: 2826226 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and benzodiazepine receptor affinity of pyrazolo[1,5-a]pyrimidine derivatives. 3. New 6-(3-thienyl) series as alpha 1 selective ligands. Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Bonaccini C; Malmberg Aiello P; Besnard F; Renard S; Costa B; Martini C J Med Chem; 2003 Jan; 46(2):310-3. PubMed ID: 12519068 [TBL] [Abstract][Full Text] [Related]
12. Dipyrazolo[5,4-b:3',4'-d]pyridines. Synthesis, inhibition of benzodiazepine receptor binding and structure-activity relationships. Melani F; Cecchi L; Colotta V; Filacchioni G; Martini C; Giannaccini G; Lucacchini A Farmaco; 1989 Jun; 44(6):585-94. PubMed ID: 2553037 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding studies of 1-arylpyrazolo[4,5-c]- and 2-arylpyrazolo[4,3-c]quinolin-4-ones. I. Cecchi L; Melani F; Palazzino G; Filacchioni G; Martini C; Pennacchi E; Lucacchini A Farmaco Sci; 1985 Jul; 40(7):509-16. PubMed ID: 2995118 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists. Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and BZR affinity of pyrazolo[1,5-a]pyrimidine derivatives. Part 1: study of the structural features for BZR recognition. Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Costa B; Martini C Bioorg Med Chem; 1999 Dec; 7(12):2705-11. PubMed ID: 10658575 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor. Rewcastle GW; Bridges AJ; Fry DW; Rubin JR; Denny WA J Med Chem; 1997 Jun; 40(12):1820-6. PubMed ID: 9191958 [TBL] [Abstract][Full Text] [Related]
17. Pyrazolo[4,5-c]quinolines. 2. Synthesis and specific inhibition of benzodiazepine receptor binding. Melani F; Cecchi L; Palazzino G; Filacchioni G; Martini C; Pennacchi E; Lucacchini A J Med Chem; 1986 Feb; 29(2):291-5. PubMed ID: 3005571 [TBL] [Abstract][Full Text] [Related]